Article Information
History
- February 24, 2022.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY 4.0 International license.
Author Information
- Hussein Kadhem Al-Hakeima,
- Ali Fattah Alhusseinib,
- Arafat Hussein Al-Dujailic,
- Monojit Debnathd and
- Michael Maese,f,g,*
- aDepartment of Chemistry, College of Science, University of Kufa, Iraq
- bDepartment of Chemistry, College of Science, University of Al-Kafeel, Iraq
- cSenior Clinical Psychiatrist at the Faculty of Medicine, University of Kufa, Iraq
- dDepartment of Human Genetics, National Institute of Mental Health and Neurosciences, Bangalore, India
- eDepartment of Psychiatry, Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand
- fDepartment of Psychiatry, Medical University of Plovdiv, Plovdiv, Bulgaria
- gIMPACT Strategic Research Centre, Deakin University, PO Box 281, Geelong, VIC, 3220, Australia
- ↵*Corresponding Author: Prof. Dr. Michael Maes, M.D., Ph.D., Department of Psychiatry, Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand., E-mail: dr.michaelmaes{at}hotmail.com, https://scholar.google.co.th/citations?user=1wzMZ7UAAAAJ&hl=th&oi=ao
Posted February 24, 2022.
The interleukin-6/interleukin-23/Thelper-17-axis as a driver of neuro-immune toxicity in the major neurocognitive psychosis or deficit schizophrenia: a precision nomothetic psychiatry analysis
